Multicentric hepatic EBV-associated smooth muscle tumors in an AIDS patient: A case report, investigation of mtor activation and review of the literature

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 4, 2011, Pages 421-429

  Shen, Qi ^a   Feng, Wei ^b   Long, Michael S ^a   Duan, Xiuzhen ^a   Jaijakul, Siraya ^a   Arias, Cesar A ^a   Brown, Robert E ^a   Zhao, Bihong ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b North Cypress Medical Center   (United States)

Author keywords

Acquired immunodeficiency syndrome; Adult; Epstein Barr virus; HIV infection; Liver; Smooth muscle tumor

Indexed keywords

ANTIVIRUS AGENT; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BIOPSY; BLOOD; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; LIVER TUMOR; MALE; METABOLISM; MUSCLE TUMOR; REVIEW; SIGNAL TRANSDUCTION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; BIOPSY; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; RNA, VIRAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TUMOR; TOMOGRAPHY, X-RAY COMPUTED; TOR SERINE-THREONINE KINASES;

EID: 80051659119     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG and Murphy SB. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995; 332: 12-18.
2. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A and Dickman PS. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19-25.
3. Boman F, Gultekin H and Dickman PS. Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi's lesion or smooth muscle tumors in immunocompetent patients. Arch Pathol Lab Med 1997; 121: 834-838.
4. Ong KW, Teo M, Lee V, Ong D, Lee A, Tan CS, Vathsala A and Toh HC. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications. Clin Cancer Res 2009; 15: 5350-5358.
5. To KF, Lai FM, Wang AY, Leung CB, Choi PC, Szeto CC, Lui SF, Yu AW and Li PK. Posttransplant Epstein-Barr virus-associated myogenic tumors involving bone. Cancer 2000; 89: 467-472.
6. Prevot S, Neris J and de Saint Maur PP. Detection of Epstein Barr virus in an hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient. Virchows Arch 1994; 425: 321-325.
7. Wang MH, Wu CT, Hung CC, Liang JD and Chen PJ. Hepatic leiomyomatous neoplasm associated with Epstein Barr virus infection in an adult with acquired immunodeficiency syndrome. J Formos Med Assoc 2000; 99: 873-875.
8. Cheuk W, Li PC and Chan JK. Epstein-Barr virusassociated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 2002; 34: 245-249.
9. Wong KH, Chan KC, Lee SS, Lai ST, Lee N, Cockram C, Poon WS, Tsang TY, Tso YK and To KF. Epstein-Barr virus-associated smooth muscle tumor in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2007; 40: 173-177.
10. Suankratay C, Shuangshoti S, Mutirangura A, Prasanthai V, Lerdlum S, Shuangshoti S, Pintong J and Wilde H. Epstein-Barr virus infectionassociated smooth-muscle tumors in patients with AIDS. Clin Infect Dis 2005; 40: 1521-1528.
11. Deyrup AT, Lee VK, Hill CE, Cheuk W, Toh HC, Kesavan S, Chan EW and Weiss SW. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006; 30: 75-82.
12. Calderaro J, Polivka M, Gallien S, Bertheau P, Thiebault JB, Molina JM and Gray F. Multifocal Epstein Barr virus (EBV)-associated myopericytoma in a patient with AIDS. Neuropathol Appl Neurobiol 2008; 34: 115-117.
13. Zevallos-Giampietri EA, Yanes HH, Orrego Puelles J and Barrionuevo C. Primary meningeal Epstein-Barr virus-related leiomyosarcoma in a man infected with human immunodeficiency virus: review of literature, emphasizing the differential diagnosis and pathogenesis. Appl Immunohistochem Mol Morphol 2004; 12: 387-391.
14. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE and Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol 4: 13-21.
15. Lang H, Nussbaum KT, Kaudel P, Fruhauf N, Flemming P and Raab R. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231: 500-505.
16. Gates LK, Jr., Cameron AJ, Nagorney DM, Goellner JR and Farley DR. Primary leiomyosarcoma of the liver mimicking liver abscess. Am J Gastroenterol 1995; 90: 649-652.
17. Gallien S, Zuber B, Polivka M, Lagrange-Xelot M, Thiebault JB, Bertheau P, Gray F and Molina JM. Multifocal Epstein-Barr virus-associated smooth muscle tumor in adults with AIDS: case report and review of the literature. Oncology 2008; 74: 167-176.
18. Okano M, Thiele GM, Davis JR, Grierson HL and Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1988; 1: 300-312.
19. Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol 2008; 39: 473-483.
20. Timens W, Boes A, Vos H and Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry 1991; 95: 605-611.
21. Bayliss GJ and Wolf H. Epstein-Barr virusinduced cell fusion. Nature 1980; 287: 164-165.
22. Kim YS, Paik SR, Kim HK, Yeom BW, Kim I and Lee D. Epstein-Barr virus and CD21 expression in gastrointestinal tumors. Pathol Res Pract 1998; 194: 705-711.
23. Wang D, Liebowitz D and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
24. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
25. Rougemont AL, Alfieri C, Fabre M, Gorska-Flipot I, Papp E, Champagne J, Phan V, Fournet JC and Sartelet H. Atypical Epstein-Barr virus (EBV) latent protein expression in EBV-associated smooth muscle tumours occurring in paediatric transplant recipients. Histopathology 2008; 53: 363-367.
26. Rogatsch H, Bonatti H, Menet A, Larcher C, Feichtinger H and Dirnhofer S. Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature. Am J Surg Pathol 2000; 24: 614-621.
27. Boudjemaa S, Boman F, Guigonis V and Boccon -Gibod L. Brain involvement in multicentric Epstein-Barr virus-associated smooth muscle tumours in a child after kidney transplantation. Virchows Arch 2004; 444: 387-391.
28. Bhaskar PT and Hay N. The two TORCs and Akt. Dev Cell 2007; 12: 487-502.
29. Holz MK, Ballif BA, Gygi SP and Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005; 123: 569-580.
30. Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA, Sawai ET and Gutkind JS. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci U S A 2004; 101: 4821-4826.
31. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP and Grandaliano G. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317-1323.
32. Toh HC, Teo M, Ong KW, Lee V, Chan E, Lee AS and Vathsala A. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour. Lancet Oncol 2006; 7: 955-957.
33. Wittek AE, Mitchell CD, Armstrong GR, Albini A, Martin GR, Seemann R, Levenbook IS, Wierenga DE, Ridge J, Dunlap RC and et al. Propagation and properties of Kaposi's sarcomaderived cell lines obtained from patients with AIDS: similarity of cultured cells to smooth muscle cells. Aids 1991; 5: 1485-1493.
34. Dhingra S, Rodriguez ME, Shen Q, Duan X, Stanton ML, Chen L, Zhang R and Brown RE. Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. Int J Clin Exp Pathol 4: 134-146.